IP Library Patent Application 13143736
Patent Application
App. No. 13/143,736

PULMONARY ADMINISTRATION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND CONSTRUCTS THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/143,736
Abstract

The present invention relates to a method wherein an immunoglobulin single variable domain (such as a Nanobody) and/or construct thereof are absorbed in pulmonary tissue. More particularly, the invention provides systemic delivery of an immunoglobulin single variable domain and/or construct thereof via the pulmonary route.

Claims (8)

1 . Method of delivering an effective amount of an immunoglobulin single variable domain and/or construct thereof to a human; wherein said immunoglobulin single variable domain and/or construct thereof is directed against at least one antigen; and wherein the method comprises the step of administering said immunoglobulin single variable domain and/or construct thereof to the pulmonary tissue.

2 . Method of claim 1 , wherein the process of administering comprises the step of forming an aerosol comprising said immunoglobulin single variable domain and/or construct thereof by an appropriate inhaler device.

3 . Method of claim 1 , wherein an effective amount of an immunoglobulin single variable domain and/or construct thereof to the systemic circulation of said human is provided.

4 . Method of claim 3 , wherein the method is able to deliver said immunoglobulin single variable domain and/or construct thereof to the systemic circulation with an absolute bioavailability that is at least 10% after administration of a single dose administration of said immunoglobulin single variable domain and/or construct thereof.

5 . Method of claim 3 , wherein the terminal half life of said immunoglobulin single variable domain and/or construct thereof in the systemic circulation is longer than 5 hours.

6 . Method of claim 1 , wherein said immunoglobulin single variable domain and/or construct thereof is a Nanobody and/or construct thereof.

7 . Method of claim 1 , wherein said immunoglobulin single variable domain and/or construct thereof is selected from the group of a Nanobody, a construct essentially consisting of two Nanobodies directed against the same or different antigens optionally connected by a linker; and a construct essentially consisting of 3 Nanobodies directed against the same or different antigens optionally connected by a linker.

8 . Method of administering an immunoglobulin single variable domain and/or construct thereof to the pulmonary tissue according to claim 1 ; wherein said administration is once a day.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2011
From: BOUCHE, MARIE-PAULE LUCIENNE ARMANDA; VANLANDSCHOOT, PETER; SABLON, ERWIN; DEPLA, ERIK; DE BUCK, STEFAN; SAELENS, XAVIER; SCHEPENS, BERT
To: ABLYNX N.V.
Reel/Frame 026853/0150 →